From: Target identification of small molecules: an overview of the current applications in drug discovery
On-bead affinity matrix approach | |||
Compound name | Structure | Target | Ref |
Encephalagen |
| Ribosomal proteins (S5, S13, S18, ad L28) | [19] |
| cryptochrome | [20] | |
Aminopurvalanol |
| CDK1 | |
BRD0476 |
| ubiquitin-specific peptidase 9X (USP9X) | [23] |
ssMP C11 |
| F1F0-ATP synthase | [24] |
Melanogenin | Prohibitin | [25] | |
Sulfonyl Amidine |
| Prohibitin | |
TWS119 |
| Glycogen synthase kinase-3 (GSK-3) | [28] |
Diminutol |
| NQO1 (an NADP-dependent oxidoreductase) | [29] |
GAPDS | Glyceraldehyde-3-phosphate dehydrogenase | [30] | |
Quinostatin |
| Class Ia PI3Ks | [31] |
SC1 |
| ERK1- and RasGAP | [32] |
QS11 |
| ARFGAP1 | [33] |
KL001 |
| cryptochrome (CRY) | [20] |
Biotin-tagged approach | |||
Withaferin |
| Type (III) intermediate fila ment (IF) protein, vimentin | [34] |
stauprimide |
| NME2 protein | [35] |
Epolactaene | Hsp (heatshock protein) 60 | [36] | |
Chromeceptin |
| MFP-2 | |
Myoseverin | Tubulin | ||
PNRI-299 |
| Redox factor 1 (Ref-1) | [40] |
BMS-790052 | HCV NS5A | [41] | |
ICG-001 |
| Cyclic AMP response element-binding protein (CBP) | [42] |
Photoaffinity tagged approach | |||
Pladienolide |
| SF3b | [43] |
HUN-7293(2) |
| Sec61α | [44] |
mono-galactosyl-diacylglycerol | TLR4 | [45] | |
kartogenin |
| Filamin A | [46] |
venetoclax |
| ITPR1GSR RER1 VDAC2 PDIA3 | [47] |
5′-I fuligocandin B |
| VCP/p97 | [48] |
SW208108 |
| SCD | [49] |
inflachromene (ICM) |
| HMGB1, HMGB2 | [50] |
pyrrolidinone compound 2 |
| fumarate hydratase | [51] |
gold N-heterocyclic carbene complex compound (1d) |
| HSP60 Vimentin NDKA NPM YB-1 PRDX1 | [52] |
S1-6 |
| Tubulin | [53] |
LL-2003 |
| IGF-1R Src | [54] |
chamuvarinin derivative compound (1) | mHSP70 ATP5F1 | [55] | |
BIX-01294 |
| PfnPrx NAPL PfHSP110c, etc. | [56] |
RYL-634 |
| DHODH | [57] |
LBL1 |
| lamin A | [58] |
Compound 9im |
| BCAP31 LPCAT3 POR TM9SF3 SCCPDH CANX | [47] |
Drug affinity responsive target stability (DARTS) | |||
5-epi-sinuleptolide |
| actin | [59] |
resveratrol |
| eIF4A | [60] |
bithionol |
| MDH3 GDH1 GND1 | [61] |
syrosingopine | α-enolase | [62] | |
Rapamycin | mTOR FKBP12 | ||
nitazoxanide |
| PAD2 | [63] |
ellagic acid |
| ACTN4 | [64] |
betulinic acid |
| GRP78 | [65] |
gephyronic acid | eIF2α | [66] | |
axitinib |
| SHPRH | [67] |
salinomycin | nucleolin | [68] | |
cryptotanshinone |
| FKBP1A | [69] |
FK506 |
| FKBP12 calcineurin | |
arctigenin | PP2A | [70] | |
Stability of Proteins from Rates of Oxidation (SPROX) | |||
tamoxifen |
| YBX-1 | [71] |
manassantin A | filamin A, EF1α | [72] | |
Cellular context thermal shift assays (CETSA) | |||
aurone derivative 1a |
| Class III PI3K (Vps34) | [73] |
ferulin C | tubulin | [74] | |
10,11-dehydrocurvularin |
| STAT3 | [75] |
Geranylnaringenin |
| SH2 domain-containing protein tyrosine phosphatase-2 (SHP-2) | [76] |
Mutagenesis | |||
KPT-9274 | nicotinamide phosphoribosyltransferase (NAMPT) | [77] | |
Picolinamide scaffolds |
| lipid-transfer protein Sec14p, the major phosphatidylinositol-transfer protein (PITP) | [78] |
Genetic screening | |||
BDW568 | STING and CES1 | [79] |